Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of the Extracorporeal Liver Assist Device (ELAD®) In Patients With Fulminant Hepatic Failure (FHF)

NCT00832728 is registered in ClinicalTrials.gov with Vital Therapies, Inc. as lead sponsor.

NCT NCT00832728
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00832728 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of the Extracorporeal Liver Assist Device (ELAD®) In Patients With Fulminant Hepatic Failure (FHF)
Lead sponsor
Vital Therapies, Inc.
Phase
Phase 2
Overall status
Withdrawn
Start date
March 31, 2009
Completion date
September 30, 2011
Enrollment
0 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

fulminant hepatic failure